Evidence map›Paper›PMID 39008777›Full record

ArticleJournal of proteome research2024

Analysis of Protein Cysteine Acylation Using a Modified Suspension Trap (Acyl-Trap).

Michael T Forrester, Jacob R Egol, Aleksandra Tata, Purushothama Rao Tata, Matthew W Foster

Abstract read
In one paragraph

Article in Journal of proteome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Michael T ForresterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina 27710, United States.ORCID 0009-0007-4665-4164
Jacob R EgolDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina 27710, United States.ORCID 0009-0000-5875-8074
Aleksandra TataDepartment of Cell Biology, Duke University School of Medicine, Durham, North Carolina 27710, United States.
Purushothama Rao TataDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina 27710, United States.
Matthew W FosterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina 27710, United States.ORCID 0000-0003-0212-2346

Funding

Molecular control of a novel transitional cell state in alveolar regenerationR01HL153375 · NHLBI · DUKE UNIVERSITY · PI Purushothama Rao Tata · 2020 to 2026
$3.4M
Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)T32HL160494 · NHLBI · DUKE UNIVERSITY · PI Jennifer L. Ingram, DAVID MARTIN MURDOCH · 2022 to 2026
$2.6M
Cellular crosstalk and molecular mechanisms in the initiation and progression of pulmonary fibrosisR01HL160939 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2022 to 2025
$2.1M
Development of a protein palmitoylation assay to monitor treatment of CLN1 Batten DiseaseR41HD105560 · NICHD · CIRCUMVENT PHARMACEUTICALS, INC. · PI FOSTER, MATTHEW WOLF, SCOTT, ANNA INGRID · 2021 to 2021
$305k
NHLBI NIH HHS R01 HL153375NHLBI NIH HHS R01 HL160939NHLBI NIH HHS T32 HL160494NICHD NIH HHS R41 HD105560
6 · The paper itself

Abstract

Proteins undergo reversible

Indexed as

CysteineTandem Mass SpectrometryAcylationAnimalsBrainChromatography, LiquidHydroxylamineLipoylationMiceProtein Processing, Post-TranslationalProteinsSulfhydryl CompoundsCysteineHydroxylamineProteinsSulfhydryl Compoundschemoproteomics S-palmitoylationcysteine proteomicsFragpipeisobaric labelingS-acylationS-TrapSuspension trappingSwisspalmthioesterTMT

Identifiers

PMID39008777
PMCPMC11826151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.